A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Aspen Global Incorporated
- Target Recruit Count
- 15
- Registration Number
- NCT03841396
Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban
Phase 3
Terminated
- Conditions
- Heparin-induced Thrombocytopenia
- Interventions
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Aspen Global Incorporated
- Target Recruit Count
- 7
- Registration Number
- NCT03809481
- Locations
- 🇵🇱
Wojewódzki Szpital Zespolony im. L. Rydygiera, Toruń, Poland
🇺🇸The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
🇺🇸University of Minnesota Medical Center, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath